Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Ilona Hering"'
Autor:
Stanislaus Reimer, Johan F. Lock, Sven Flemming, Alexander Weich, Anna Widder, Lars Plaßmeier, Anna Döring, Ilona Hering, Mohammed K. Hankir, Alexander Meining, Christoph-Thomas Germer, Kaja Groneberg, Florian Seyfried
Publikováno v:
Frontiers in Surgery, Vol 9 (2022)
BackgroundEndoscopic vacuum therapy (EVT) is an evidence-based option to treat anastomotic leakages of the upper gastrointestinal (GI) tract, but the technical challenges and clinical outcomes of patients with large defects remain poorly described.Me
Externí odkaz:
https://doaj.org/article/43cc35d02ce44c6788ba976e23cae198
Autor:
Stanislaus, Reimer, Florian, Seyfried, Sven, Flemming, Markus, Brand, Alexander, Weich, Anna, Widder, Lars, Plaßmeier, Peter, Kraus, Anna, Döring, Ilona, Hering, Mohammed K, Hankir, Alexander, Meining, Christoph-Thomas, Germer, Johan F, Lock, Kaja, Groneberg
Publikováno v:
Surgical Endoscopy. 36:9169-9178
Background Endoscopic vacuum therapy (EVT) is an effective treatment option for leakage of the upper gastrointestinal (UGI) tract. The aim of this study was to evaluate the clinical impact of quality improvements in EVT management on patients’ outc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::665d38a1985e6580b9871cbd0f9e3ec6
https://doi.org/10.1007/s00464-022-09400-w
https://doi.org/10.1007/s00464-022-09400-w
Autor:
Ilona Hering, Luise Dörries, Sven Flemming, Laura Krietenstein, Ann-Kathrin Koschker, Martin Fassnacht, Christoph-Thomas Germer, Mohammed K. Hankir, Florian Seyfried
Publikováno v:
Langenbeck's Archives of Surgery. 407:1873-1879
Background An intragastric balloon is used to cause weight loss in super-obese patients (BMI > 60 kg/m2) prior to bariatric surgery. Whether weight loss from intragastric balloon influences that from bariatric surgery is poorly studied. Methods In th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f31307b6d0630730c2bcbf16c4bae520
https://doi.org/10.1007/s00423-022-02472-1
https://doi.org/10.1007/s00423-022-02472-1
Publikováno v:
Adipositas - Ursachen, Folgeerkrankungen, Therapie. 14:190-198
ZusammenfassungDie Adipositas- bzw. metabolische Chirurgie stellt derzeit evidenzbasiert die einzige Therapiemodalität dar, die bei Patienten mit drittgradiger Adipositas zu einem nachhaltigen und auch klinisch relevanten Gewichtsverlust, zu einer V
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d0fa10327a1eda6faab5122b10878a72
https://doi.org/10.1055/a-1260-4795
https://doi.org/10.1055/a-1260-4795
Autor:
Ilona Hering, Florian Seyfried
Publikováno v:
Nicht-alkoholische Fettlebererkrankung ISBN: 9783662624838
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c44536795fcbb57787dee49e2baf19ba
https://doi.org/10.1007/978-3-662-62484-5_28
https://doi.org/10.1007/978-3-662-62484-5_28
Publikováno v:
Adipositas - Ursachen, Folgeerkrankungen, Therapie. 13:214-221
Zusammenfassung Derzeit ist die metabolische/bariatrische Chirurgie die einzige evidenzbasierte Therapie, die bei einem Großteil der morbid adipösen Patienten zu einer relevanten und nachhaltigen Gewichtsabnahme und Verbesserung der Adipositas-asso
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::891c864ac00a43fc5e50b3c2940a5c58
https://doi.org/10.1055/a-0966-9835
https://doi.org/10.1055/a-0966-9835
Autor:
Theodor Kudlich, Ann-Kathrin Koschker, Monika Rau, Jan Meertens, Christian Jurowich, Ilona Hering, Andreas Geier, Lisa Reichert, Johannes Weiss
Publikováno v:
Scandinavian Journal of Gastroenterology. 51:1263-1268
Prevalence of non-alcoholic fatty liver disease is rising in the Western world and reaches up to 90% in patients undergoing bariatric surgery. Fibroscan(®) as a non-invasive tool for liver stiffness measurement (LSM) has several limitations in morbi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::072660513f94f5139e4a7851b4e76577
https://doi.org/10.1080/00365521.2016.1191084
https://doi.org/10.1080/00365521.2016.1191084
Autor:
Niklas Beyersdorf, Anne-Kristin Schilling, Monika Rau, Christian Jurowich, Ilona Hering, Theodor Kudlich, Johannes M. Weiss, Heike Bantel, Andreas Geier, Jan Meertens, Heike M. Hermanns
Publikováno v:
The Journal of Immunology. 196:97-105
Nonalcoholic fatty liver disease is increasing in prevalence. It can be subdivided into nonalcoholic fatty liver (NAFL) and nonalcoholic steatohepatitis (NASH). Five to twenty percent of cases progress from NAFL to NASH. Increased hepatic Th17 cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c1b6329aa565db2e395612ca1ca0bb1
https://doi.org/10.4049/jimmunol.1501175
https://doi.org/10.4049/jimmunol.1501175